Mast Cell Tumors Flashcards
What markers are MCT positive for?
vimentin, tryptase, and CD117 (KIT) positive
Treatment of choice for MCT localized to the skin in areas amenable to wide excision
surgery
Surgical margins for MCT
- Historically, surgical excision to include a 3-cm margin
- Metric approach uses a prescribed metric distance, with lateral margins of 1 cm and 2 cm for low- and intermediate-grade MCTs
- Proportional approach uses lateral margins proportional to the maximum dimension of the MCT.
- For both approaches, deep margins include removal of one uninvolved fascial plane in continuity with the tumor.
Treatment options of MCT if primary closure is not possible regardless of the width of the lateral margins
- Wide excision +/-chemotherapy depending on histologic grading
- Marginal excision followed by adjuvant therapy
Two-year control rates for stage 0 tumors of low- or intermediate-grade MCTs treated with surgery followed by RT
85% to 95%
Treatment options after curative excision surgery is unsuccessful and histologic margins are incomplete
- Scar revision surgery
- RT
% of regrowth in MCTs with histologically confirmed incomplete margins
10-30%
Treatment for poorly differentiated and metastatic MCT
Surgery (if possible) followed by systemic chemotherapy for best response
Corticosteroids role in MCT treatment
Inhibit canine MCT proliferation and induce tumor cell apoptosis
May also contribute to apparent antitumor response by decreasing peritumoral edema and inflammation
Cytotoxic chemotherapy protocols for MCT
Vinblastine + pred
CCNU + Vinblastine + pred
Vinblastine + cyclophosphamide + pred
ORR to toceranib in dogs with recurrent or metastatic intermediate- or high-grade MCTs
~45%
C-kit mutation correlation to toceranib response
Dogs with mutations in the c-kit gene were roughly twice as likely to respond to TOC than those with wild-type c-kit
Tyrosine kinase inhibitors used for MCT
Toceranib, masitinib, imatinib
ORR and MST of toceranib, pred, and hypofractionated RT in dogs with unresectable and/or metastatic MCTs
~80%
CR - 60%
PR 20%
MST not reached (follow up 1 year)
Ancillary treatment to minimize the
effects of histamine release
H1 blockers diphenhydramine or chlorpheniramine
H2 blockers cimetidine, famotidine, or ranitidine
Proton pump inhibitor omeprazole
Dog mast cell tumors in which locations carry worse prognosis?
AH
Subungual (nail bed)
Oral
Other mucous membrane sites
Preputial
Scrotal
Visceral & bone marrow = grave
Which cell proliferation indexes are prognostic for canine mast cell tumors?
AH
Mitotic index
Relative frequency of AgNORs
Percent PCNA
Percent Ki-67
Which breeds of dogs with MCTs have a better prognosis?
AH
boxers and potentially other brachycephalic breeds
What is the difference between the composition of mast cell granules in the GI and skin?
AH
GI MCs express primarily chymase
Skin MCs express both chymase and tryptase
The presence of which molecule is required for the differentiation of human and canine bone marrow derived mast cells?
AH
Stem cell factor (SCF)
Why dogs exhibit such a high degree of hypersensitivity to several chemical agents including polysorbate 80, cremophor EL, and doxorubicin?
BONUS QUESTION: Do you remember what polysorbate 80 and cremaphor EL are?
AH
Canine bone marrow derived mast cells (cBMMCs) are exteremely sensitive to chemical degranulation.
Polysorbate 80 and Cremophor EL are both non-ionic surfactants commonly used in pharmaceutical formulations, particularly as solubilizers for poorly water-soluble drugs, but they are different brand names for essentially the same type of chemical compound - a polyethoxylated castor oil
Cremaphor EL: paclitaxel
Polysorbate 80: docetaxel, etoposide
That’s why IV administration of these drugs causes severe hypersensitivity.
Which genes are risk factors for the development of MCTs in golden retrievers?
AH
Polymorphisms in the GNAI2 gene and multiple genes associated with hyaluronic acid synthesis.
How do estrogen and progesterone influence canine MCTs?
AH
Their role is unclear, but European studies suggest female dogs may have better chemotherapy outcomes. US studies did not find the same effect probably because of the higher number of intact dogs in Europe.
What angiogenic growth factors are linked to canine MCTs?
AH
VEGF and its receptor VEGFR2; VEGFR2 activation may be linked to worse post-surgical outcomes.